University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation

In this interview, we visited the UNSW campus to speak with Professor Merlin Crossley, Deputy Vice-Chancellor of Academic Quality at UNSW, Dr. Paul Watt, Executive Chairman & CSO of Avicena, and Professor Ewa Goldys, Scientia Professor at UNSW. Professor Crossley discusses UNSW’s 75-year innovation-forward mission and its groundbreaking research on genetic diseases. Dr. Watt provides insights into Avicena’s cutting-edge diagnostic systems, while Professor Goldys offers a closer look at the labs and the exciting partnership between UNSW and Avicena, highlighting their collaborative efforts in advancing biosecurity and diagnostic technologies.